Sexually Transmitted Diseases (STD) Diagnostics Market - 2025-2033

July 2025 | 73 pages | ID: S8B9B669C7C5EN
DataM Intelligence

Abstracts

Sexually Transmitted Diseases (STD) Diagnostics Market reached US$ 10.6 billion in 2024 and is expected to reach US$ 19.4 billion by 2033, growing with a CAGR of 7.10% during the forecast period 2026-2033.

The Sexually Transmitted Diseases (STD) Diagnostics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Sexually Transmitted Diseases (STD) Diagnostics Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Product Type

• Instruments*
• Consumables
• Software

By Disease Type

• Chlamydia*
• Genital Herpes
• Gonorrhea
• Hepatitis B
• HIV/AIDS
• Human papillomavirus (HPV)
• Syphilis
• Others

By Diagnostic Test Type

• Molecular Tests*
• Serologic Tests
• Point-of-Care (PoC) Tests
• Others

By End-User

• Hospitals*
• Specialty Clinics
• Diagnostic Laboratories
• Homecare Settings
• Others

Regional Analysis for Sexually Transmitted Diseases (STD) Diagnostics Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Sexually Transmitted Diseases (STD) Diagnostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Disease Type
2.5. Snippet by Diagnostic Test Type
2.6. Snippet by End-User
2.7. Snippet by Region

3. DYNAMICS

3.1. Impacting Factors
  3.1.1. Drivers
    3.1.1.1. Rising Advancements in STD Self-Diagnostics
  3.1.2. Restraints
    3.1.2.1. Limited Awareness and Education
  3.1.3. Opportunity
  3.1.4. Impact Analysis

4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

4.1. Market Leaders and Pioneers
  4.1.1. Emerging Pioneers and Prominent Players
  4.1.2. Established leaders with largest selling Brand
  4.1.3. Market leaders with established Product
4.2. Emerging Startups and Key Innovators
4.3. CXO Perspectives
4.4. Latest Developments and Breakthroughs
4.5. Case Studies/Ongoing Research
4.6. Regulatory and Reimbursement Landscape
  4.6.1. North America
  4.6.2. Europe
  4.6.3. Asia Pacific
  4.6.4. Latin America
  4.6.5. Middle East & Africa
4.7. Porter’s Five Force Analysis
4.8. Supply Chain Analysis
4.9. Patent Analysis
4.10. SWOT Analysis
4.11. Unmet Needs and Gaps
4.12. Recommended Strategies for Market Entry and Expansion
4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.14. Pricing Analysis and Price Dynamics

5. SEXUALLY TRANSMITTED DISEASES (STD) DIAGNOSTICS MARKET, BY PRODUCT TYPE

5.1. Introduction
  5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  5.1.2. Market Attractiveness Index, By Product Type
5.2. Instruments*
  5.2.1. Introduction
  5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Consumables
5.4. Software

6. SEXUALLY TRANSMITTED DISEASES (STD) DIAGNOSTICS MARKET, BY DISEASE TYPE

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  6.1.2. Market Attractiveness Index, By Disease Type
6.2. Chlamydia*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Genital Herpes
6.4. Gonorrhea
6.5. Hepatitis B
6.6. HIV/AIDS
6.7. Human papillomavirus (HPV)
6.8. Syphilis
6.9. Others

7. SEXUALLY TRANSMITTED DISEASES (STD) DIAGNOSTICS MARKET, BY DIAGNOSTIC TEST TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnostic Test Type
  7.1.2. Market Attractiveness Index, By Diagnostic Test Type
7.2. Molecular Tests*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Serologic Tests
7.4. Point-of-Care (PoC) Tests
7.5. Others

8. SEXUALLY TRANSMITTED DISEASES (STD) DIAGNOSTICS MARKET, BY END-USER

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Diagnostic Laboratories
8.5. Homecare Settings
8.6. Others

9. SEXUALLY TRANSMITTED DISEASES (STD) DIAGNOSTICS MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  9.1.2. Market Attractiveness Index, By Region
9.2. North America
  9.2.1. Introduction
  9.2.2. Key Region-Specific Dynamics
  9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnostic Test Type
  9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.2.7.1. U.S.
    9.2.7.2. Canada
    9.2.7.3. Mexico
9.3. Europe
  9.3.1. Introduction
  9.3.2. Key Region-Specific Dynamics
  9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnostic Test Type
  9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.3.7.1. Germany
    9.3.7.2. U.K.
    9.3.7.3. France
    9.3.7.4. Spain
    9.3.7.5. Italy
    9.3.7.6. Rest of Europe
9.4. South America
  9.4.1. Introduction
  9.4.2. Key Region-Specific Dynamics
  9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnostic Test Type
  9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.4.7.1. Brazil
    9.4.7.2. Argentina
    9.4.7.3. Rest of South America
9.5. Asia-Pacific
  9.5.1. Introduction
  9.5.2. Key Region-Specific Dynamics
  9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnostic Test Type
  9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.5.7.1. China
    9.5.7.2. India
    9.5.7.3. Japan
    9.5.7.4. South Korea
    9.5.7.5. Rest of Asia-Pacific
9.6. Middle East and Africa
  9.6.1. Introduction
  9.6.2. Key Region-Specific Dynamics
  9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnostic Test Type
  9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking

11. COMPANY PROFILES

11.1. Abbott Laboratories*
  11.1.1. Company Overview
  11.1.2. Product Portfolio and Description
  11.1.3. Financial Overview
  11.1.4. Key Developments
  11.1.5. SWOT Analysis
11.2. Becton, Dickinson, and Company
11.3. F. Hoffmann-La Roche Ltd.
11.4. Bio-Rad Laboratories, Inc.
11.5. Thermo Fisher Scientific Inc.
11.6. Hologic, Inc.
11.7. QIAGEN N.V.
11.8. Diasorin S.p.A.
11.9. Seegene Inc.
11.10. Bosch Healthcare Solutions GmbH (*LIST NOT EXHAUSTIVE)

12. ASSUMPTION AND RESEARCH METHODOLOGY

12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation

13. APPENDIX

13.1. About Us and Services
13.2. Contact Us